Instead, wait until the following Saturday (nine-day gap), then continue on Saturdays
Unlike GLP-1, GIP doesnt significantly slow gastric emptying
Weight management research If weight management is the primary objective, you will likely escalate to 8mg or 12mg maintenance
The SURPASS-1 trial investigated the efficacy and safety of the three doses of 5, 10, or 15 mg tirzepatide in drug-nave patients with T2D who were not sufficiently controlled with a lifestyle intervention with diet and exercise versus placebo (70)
But from deep concern about how quickly weight-loss medication is being normalised without enough conversation about metabolism, gut health and long-term healing
Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: a randomized dose-ranging study